Results 221 to 230 of about 527,601 (286)

Protocol for implementation of intraoperative adverse event recording during WHO checklist sign-out. [PDF]

BMJ Open Qual
Burri-Winkler K, Auderset AC, Hahnloser D, Burkhart CS, Neuhaus V, Gass JM, Vogt AP, Prouse G, Winkens J, Haller G, Van Vegten A, Kita Z, Finsterwald M, Schindler C, Streit N, Willms LM, Steiner LA, Clack L, Dell-Kuster S.   +18 more
europepmc   +1 more source

Membrane Fusion‐Inspired Nanomaterials: Emerging Strategies for Infectious Disease and Cancer Diagnostics

Advanced Healthcare Materials, EarlyView.
Membrane fusion‐inspired nanomaterials offer transformative potential in diagnostics by mimicking natural fusion processes to achieve highly sensitive and specific detection of disease biomarkers. This review highlights recent advancements in nanomaterial functionalization strategies, signal amplification systems, and stimuli‐responsive fusion designs,
Sojeong Lee, Khulan Nyamzaya, Jueun Han, Yejin Song, Jihee Lee, Jung Hyun Jo, Seungmin Bang, Eun‐Kyung Lim, Seungjoo Haam, Eunjung Kim   +9 more
wiley   +1 more source

Lack of Association Between Pregnancy and Selected Gastrointestinal Adverse Events Among Women Prescribed Nelfinavir

, 2001
Gary Reiss, Megan O’Brien, Jeff Kopicko, Rebecca A. Clark   +3 more
openalex   +1 more source

Microphysiological Systems for Comorbidity Studies: Chronic Kidney Disease and Osteoarthritis

Advanced Healthcare Materials, EarlyView.
This review highlights the potential of organ‐on‐a‐chip systems for studying comorbidities, using chronic kidney disease (CKD) and osteoarthritis (OA) as examples. It summarizes recent advances in kidney‐on‐a‐chip and joint‐on‐a‐chip models and discusses their current and potential application in investigating CKD, OA, and CKD‐OA comorbidity, aiming to
Mingying Han, Weiping Lin, Yuanxiong Cao, Patricia Murray, Bettina Wilm, Stephen J McWilliam, Jude Curran, Ruoxiao Xie   +7 more
wiley   +1 more source

The real-world safety of Nivolumab: a pharmacovigilance analysis based on the FDA adverse event reporting system. [PDF]

Front Immunol
Wu Y, Zhou Y, Xia S, Meng Z.
europepmc   +1 more source

Dendrimer Conjugates with PD‐L1‐Binding Peptides Enhance In Vivo Antitumor Immune Response

Advanced Healthcare Materials, EarlyView.
In this paper, a novel nanoparticle scaffold composed of dendrimers conjugated with peptide‐based immune checkpoint inhibitors, enhancing drug delivery efficacy is introduced. By conjugating PD‐L1‐binding peptides to dendrimers, multivalent binding effects are harnessed, resulting in enhanced binding affinity, prolonged half‐life, and improved ...
DaWon Kim, Jin Woong Lee, Piper A. Rawding, Mari Iida, Carter Kim, Kourtney L. Kostecki, Michael J. Poellmann, Bridget Crossman, Ashley S. Liu, YoungSoo Kim, Deric L. Wheeler, Seungpyo Hong   +11 more
wiley   +1 more source

Real-world safety assessment of Ixekizumab based on the FDA Adverse Event Reporting System (FAERS). [PDF]

PLoS One
Cheng Y, Ma J, Niu J.
europepmc   +1 more source

The Kidney in Congestive Heart Failure: Renal Adverse Event Rate of Treatment

, 2001
Christian Delles, Roland E. Schmieder
openalex   +1 more source

Progress of Immune‐Inducible Biomaterials for Post‐Ablation Cancers

Advanced Healthcare Materials, EarlyView.
The presence of residual tumors after ablative therapies poses a significant challenge, generally resulting in recurrence and metastases. This review offers a concise overview of immune‐inducible biomaterials from the perspective of the cancer‐immunity cycle, and how they enhance antitumor immunity through diverse mechanisms following ablative ...
Shuangshuang Zhao, Zheng Zhang, Xincai Wu, Yanwei Chen, Wenjun Li, Jiayan Bao, Xin Zhang, Baoding Chen   +7 more
wiley   +1 more source

Causes of drug-induced photosensitivity: an analysis using FDA adverse event reporting system database. [PDF]

Sci Rep
Ge L, Huang X, Dong Z, Zhong T.
europepmc   +1 more source